# A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus

> **NCT01071850** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 412 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** ipragliflozin
- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01071850
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03-03
- **Primary completion:** 2011-04-11
- **Final completion:** 2011-04-11
- **Target enrollment:** 412 (ACTUAL)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01071850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01071850, "A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01071850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*